The licensing effect of IFN-γ was also confirmed in primary human monocytes from ROSAH syndrome patients displaying the ALPK1 p.T237M variant. The gene discussed is ALPK1; the disease is retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome.